169.74
前日終値:
$167.78
開ける:
$167.35
24時間の取引高:
351.31K
Relative Volume:
0.16
時価総額:
$47.88B
収益:
$7.23B
当期純損益:
$1.41B
株価収益率:
34.09
EPS:
4.979
ネットキャッシュフロー:
$1.09B
1週間 パフォーマンス:
-3.23%
1か月 パフォーマンス:
+12.39%
6か月 パフォーマンス:
+46.82%
1年 パフォーマンス:
+19.70%
Agilent Technologies Inc Stock (A) Company Profile
名前
Agilent Technologies Inc
セクター
電話
(408) 345-8886
住所
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, NTRA, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
169.82 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
|
TMO
Thermo Fisher Scientific Inc
|
666.16 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
218.15 | 150.48B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
417.61 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
IQV
Iqvia Holdings Inc
|
263.27 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-20 | 開始されました | HSBC Securities | Buy |
| 2026-01-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-12-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-02 | 開始されました | Morgan Stanley | Overweight |
| 2025-10-08 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-10-08 | アップグレード | UBS | Neutral → Buy |
| 2025-02-10 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-04-05 | アップグレード | Stifel | Hold → Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-11-17 | ダウングレード | UBS | Buy → Neutral |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-31 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-05-24 | 繰り返されました | Barclays | Equal Weight |
| 2023-05-24 | 繰り返されました | BofA Securities | Buy |
| 2023-05-24 | 繰り返されました | Citigroup | Neutral |
| 2023-05-24 | 繰り返されました | Credit Suisse | Outperform |
| 2023-05-24 | 繰り返されました | Evercore ISI | Outperform |
| 2023-05-24 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-05-24 | 繰り返されました | SVB Securities | Outperform |
| 2023-05-24 | 繰り返されました | Stifel | Hold |
| 2023-05-24 | 繰り返されました | TD Cowen | Outperform |
| 2023-05-24 | 繰り返されました | Wells Fargo | Overweight |
| 2023-05-11 | 開始されました | Barclays | Equal Weight |
| 2023-01-10 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2022-07-08 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | 繰り返されました | BofA Securities | Buy |
| 2022-02-23 | 繰り返されました | Citigroup | Buy |
| 2022-02-23 | 繰り返されました | Cowen | Outperform |
| 2022-02-23 | 繰り返されました | Evercore ISI | Outperform |
| 2022-02-23 | 繰り返されました | Stifel | Hold |
| 2022-02-23 | 繰り返されました | Wells Fargo | Overweight |
| 2021-11-23 | 繰り返されました | BofA Securities | Buy |
| 2021-11-23 | 繰り返されました | Cowen | Outperform |
| 2021-11-23 | 繰り返されました | Stifel | Hold |
| 2021-03-18 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-25 | アップグレード | UBS | Neutral → Buy |
| 2020-11-17 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | 開始されました | Atlantic Equities | Neutral |
| 2020-08-19 | 繰り返されました | BofA Securities | Neutral |
| 2020-08-19 | 繰り返されました | Citigroup | Neutral |
| 2020-08-19 | 繰り返されました | Jefferies | Buy |
| 2020-08-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2020-08-19 | 繰り返されました | SVB Leerink | Outperform |
| 2020-08-19 | 繰り返されました | Stifel | Hold |
| 2020-08-19 | 繰り返されました | Wells Fargo | Overweight |
| 2020-02-24 | ダウングレード | Needham | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-11-26 | 繰り返されました | Needham | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | UBS | Buy → Neutral |
| 2019-07-16 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | ダウングレード | Barclays | Overweight → Equal Weight |
すべてを表示
Agilent Technologies Inc (A) 最新ニュース
Agilent Introduces NovoStation Sample Prep System to Automate Flow Cytometry Workflows - Contract Pharma
$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today - Benzinga
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report? - Zacks Investment Research
Agilent Technologies (A) Launches NovoStation Automation System to Enhance Flow Cytometry Workflow - GuruFocus
A 30-sample lab process took 7.9 minutes of hands-on time with Agilent's system, versus 85.5 minutes manually. - Stock Titan
Agilent Technologies, Inc. (A) Stock Forecasts - Yahoo Finance
Agilent Technologies Inc. Introduces Agilent Biotek Gen5 Ai Cell Identification Module - marketscreener.com
Bullish on Agilent Technologies Inc - theglobeandmail.com
Agilent Ekes on Launch of BioTek - Baystreet.ca
Agilent launches AI cell identification software module - Investing.com
Agilent launches AI cell identification software module By Investing.com - Investing.com Canada
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers - Yahoo Finance
Agilent Technologies Inc. stock outperforms competitors on strong trading day - MarketWatch
Agilent Technologies Inc (A): GF Score of 96 Signals Strong Outp - GuruFocus
BofA Securities Maintains Agilent Technologies(A.US) With Buy Rating, Maintains Target Price $180 - Moomoo
Agilent Technologies stock follows a Q3 beat as targets diverge - AD HOC NEWS
Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story - Yahoo Finance
Agilent Technologies stock trades at USD 172.68 near its 52-week high - AD HOC NEWS
Agilent (A) Up 9.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Agilent Technologies stock gains 3.9 percent ahead of the open - AD HOC NEWS
Agilent Technologies Inc (A) Shares Surge 4.5% -- What GF Score of 93 Tells Investors - GuruFocus
Form 8K Agilent Technologies For: 24 September By Investing.com - Investing.com Canada
Why Agilent Technologies (A) Stock Is Up Today - Moomoo
Agilent Technologies stock hits 52-week high at 169.07 USD - Investing.com
Agilent Technologies stock reports 8.1 percent revenue growth - AD HOC NEWS
AGILENT TECHNOLOGIES, INC. SEC Filing (Sep 24, 2026) - Stock Titan
Agilent Technologies stock slips before the bell - AD HOC NEWS
If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now - Eastern Progress
Agilent Technologies Sees Growth From China, Replacement Cycles and Lab Automation - Yahoo Finance
Agilent Technologies Analysis: 3.29% Surge Highlights Strong Momentum - The Cryptonomist
Agilent Technologies at U.S. All Stars Conference: growth broadens By Investing.com - Investing.com Canada
Agilent Technologies at U.S. All Stars Conference: growth broadens - Investing.com
Why Did Agilent Technologies (A) Shares Climb After Its Latest Update? - Simply Wall Street
Agilent Technologies price pierces price targetForecast today22-09-2026 - Economies.com
Agilent Technologies stock gains 3.3 percent on strong results - AD HOC NEWS
Research Tools & Consumables Stocks Q2 Highlights: Agilent (NYSE:A) - TradingView
Agilent Technologies stock heads into the open after a 3.3% gain - AD HOC NEWS
Agilent Technologies Inc (A) Stock Up 3.5% but GF Value Says Ove - GuruFocus
Agilent Technologies stock gains on TapeStationDx launch and raised EPS guidance - AD HOC NEWS
Agilent Launches TapeStationDx Systems for Clinical NGS Sample Quality Control - BioSpace
Agilent launches clinical lab systems for DNA, RNA analysis By Investing.com - Investing.com Nigeria
Goldman Sachs Maintains Agilent Technologies(A.US) With Buy Rating, Raises Target Price to $185 - moomoo.com
Agilent launches clinical lab systems for DNA, RNA analysis - Investing.com
Goldman Sachs Adjusts PT on Agilent Technologies to $185 From $175, Maintains Buy Rating - moomoo.com
Agilent Technologies, Inc. (A) Stock Analysis: Unveiling a 11.81% Potential Upside in Diagnostics & Research - DirectorsTalk Interviews
Agilent Technologies stock heads into the open after a modest gain - AD HOC NEWS
Agilent Technologies stock rises on August 26 guidance lift - AD HOC NEWS
Agilent (A) Wants Pathology Labs To Go Digital, 540 Slides At A Time - Yahoo Finance
Agilent Technologies stock gains on fresh scanner launch and dividend - AD HOC NEWS
Is FDA Cleared Scanner Launch Altering The Investment Case For Agilent Stock? - simplywall.st
Agilent Technologies Inc. 2017 Q3ResultsEarnings Call Slides (NYSE:A) 2017-08-15 - Seeking Alpha
Agilent Technologies Inc (A) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):